Ionis Pharmaceuticals, Inc. (IONS)
73.81
+0.49
(+0.67%)
USD |
NASDAQ |
Jun 11, 16:00
73.81
0.00 (0.00%)
After-Hours: 18:51
Ionis Pharmaceuticals Accounts Payable (Quarterly) : 26.03M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 26.03M |
| December 31, 2025 | 28.08M |
| September 30, 2025 | 14.33M |
| June 30, 2025 | 22.80M |
| March 31, 2025 | 17.46M |
| December 31, 2024 | 42.96M |
| September 30, 2024 | 9.052M |
| June 30, 2024 | 9.243M |
| March 31, 2024 | 13.08M |
| December 31, 2023 | 26.03M |
| September 30, 2023 | 5.615M |
| June 30, 2023 | 24.02M |
| March 31, 2023 | 10.50M |
| December 31, 2022 | 17.92M |
| September 30, 2022 | 20.54M |
| June 30, 2022 | 10.35M |
| March 31, 2022 | 16.12M |
| December 31, 2021 | 11.90M |
| September 30, 2021 | 8.357M |
| June 30, 2021 | 14.66M |
| March 31, 2021 | 9.506M |
| December 31, 2020 | 17.20M |
| September 30, 2020 | 16.22M |
| June 30, 2020 | 7.407M |
| March 31, 2020 | 21.17M |
| Date | Value |
|---|---|
| December 31, 2019 | 16.07M |
| September 30, 2019 | 13.15M |
| June 30, 2019 | 15.63M |
| March 31, 2019 | 13.33M |
| December 31, 2018 | 28.66M |
| September 30, 2018 | 13.58M |
| June 30, 2018 | 13.29M |
| March 31, 2018 | 13.83M |
| December 31, 2017 | 24.89M |
| September 30, 2017 | 23.52M |
| June 30, 2017 | 13.27M |
| March 31, 2017 | 23.24M |
| December 31, 2016 | 21.12M |
| September 30, 2016 | 15.68M |
| June 30, 2016 | 17.58M |
| March 31, 2016 | 19.46M |
| December 31, 2015 | 28.36M |
| September 30, 2015 | 19.29M |
| June 30, 2015 | 10.95M |
| March 31, 2015 | 16.49M |
| December 31, 2014 | 17.98M |
| September 30, 2014 | 15.63M |
| June 30, 2014 | 13.45M |
| March 31, 2014 | 9.869M |
| December 31, 2013 | 11.01M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 126.63M |
| Biogen, Inc. | 358.50M |
| BioMarin Pharmaceutical, Inc. | 395.47M |
| BridgeBio Pharma, Inc. | 29.06M |
| Mirum Pharmaceuticals, Inc. | 59.40M |